Ontology type: schema:ScholarlyArticle
2014-01-04
AUTHORSV. Benseler, N. Obermajer, C. L. Johnson, Y. Soeder, M. D. Dahlke, F. C. Popp
ABSTRACTImmunomodulatory cell therapy as a complement to standard pharmacotherapy represents a novel approach to solid organ allograft acceptance. This methodology may allow for a reduced dose of immunosuppressive drug to be administered and thus attenuate the severe side effects associated with long-term immunosuppression such as drug-related impairment of renal function, increased risk from opportunistic infections and malignancies. Mesenchymal stem cells (MSCs) have been shown to possess both immune modulatory and regenerative properties in vitro and in preclinical models. Encouraging results have been reported from studies examining the safety and efficacy of MSCs as a treatment for acute graft-versus-host disease. MSCs represent a promising candidate cell therapy to supplement immunosuppression in recipients of solid organs, and initial reports on the clinical use of MSCs in kidney transplantation have been recently published (Tan et al. in J Am Med Assoc 307:1169–1177, 2012; Reinders et al. in Stem Cells Transl Med 2:107–111, 2013; Perico et al. in Transpl Int 26:867–878, 2013; Perico et al. in Clin J Am Soc Nephrol 6:412–422, 2011). An area of even greater interest might be the application of MSCs in clinical liver transplantation as graft survival is closely associated with overall patient survival. Here, we present preclinical findings and discuss their possible impact on clinical liver transplantation. Then we discuss clinical studies designed to investigate how MSCs may be distributed and act in solid organ transplantation. More... »
PAGES179-184
http://scigraph.springernature.com/pub.10.1007/s12072-013-9509-1
DOIhttp://dx.doi.org/10.1007/s12072-013-9509-1
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1003810089
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/26202500
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Surgery, University of Regensburg, Regensburg, Germany",
"id": "http://www.grid.ac/institutes/grid.7727.5",
"name": [
"Department of Surgery, University of Regensburg, Regensburg, Germany"
],
"type": "Organization"
},
"familyName": "Benseler",
"givenName": "V.",
"id": "sg:person.01215502761.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215502761.03"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, University of Regensburg, Regensburg, Germany",
"id": "http://www.grid.ac/institutes/grid.7727.5",
"name": [
"Department of Surgery, University of Regensburg, Regensburg, Germany"
],
"type": "Organization"
},
"familyName": "Obermajer",
"givenName": "N.",
"id": "sg:person.0733752407.06",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733752407.06"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, University of Regensburg, Regensburg, Germany",
"id": "http://www.grid.ac/institutes/grid.7727.5",
"name": [
"Department of Surgery, University of Regensburg, Regensburg, Germany"
],
"type": "Organization"
},
"familyName": "Johnson",
"givenName": "C. L.",
"id": "sg:person.01152147001.88",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152147001.88"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, University of Regensburg, Regensburg, Germany",
"id": "http://www.grid.ac/institutes/grid.7727.5",
"name": [
"Department of Surgery, University of Regensburg, Regensburg, Germany"
],
"type": "Organization"
},
"familyName": "Soeder",
"givenName": "Y.",
"id": "sg:person.01013422664.32",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013422664.32"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, University of Regensburg, Regensburg, Germany",
"id": "http://www.grid.ac/institutes/grid.7727.5",
"name": [
"Department of Surgery, University of Regensburg, Regensburg, Germany"
],
"type": "Organization"
},
"familyName": "Dahlke",
"givenName": "M. D.",
"id": "sg:person.011340433274.43",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011340433274.43"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Surgery, University of Regensburg, Regensburg, Germany",
"id": "http://www.grid.ac/institutes/grid.7727.5",
"name": [
"Department of Surgery, University of Regensburg, Regensburg, Germany"
],
"type": "Organization"
},
"familyName": "Popp",
"givenName": "F. C.",
"id": "sg:person.01001741457.76",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001741457.76"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1186/1479-5876-9-124",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1026411869",
"https://doi.org/10.1186/1479-5876-9-124"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nm.1905",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1027601999",
"https://doi.org/10.1038/nm.1905"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/223472a0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1033985475",
"https://doi.org/10.1038/223472a0"
],
"type": "CreativeWork"
}
],
"datePublished": "2014-01-04",
"datePublishedReg": "2014-01-04",
"description": "Immunomodulatory cell therapy as a complement to standard pharmacotherapy represents a novel approach to solid organ allograft acceptance. This methodology may allow for a reduced dose of immunosuppressive drug to be administered and thus attenuate the severe side effects associated with long-term immunosuppression such as drug-related impairment of renal function, increased risk from opportunistic infections and malignancies. Mesenchymal stem cells (MSCs) have been shown to possess both immune modulatory and regenerative properties in vitro and in preclinical models. Encouraging results have been reported from studies examining the safety and efficacy of MSCs as a treatment for acute graft-versus-host disease. MSCs represent a promising candidate cell therapy to supplement immunosuppression in recipients of solid organs, and initial reports on the clinical use of MSCs in kidney transplantation have been recently published (Tan et al. in J Am Med Assoc 307:1169\u20131177, 2012; Reinders et al. in Stem Cells Transl Med 2:107\u2013111, 2013; Perico et al. in Transpl Int 26:867\u2013878, 2013; Perico et al. in Clin J Am Soc Nephrol 6:412\u2013422, 2011). An area of even greater interest might be the application of MSCs in clinical liver transplantation as graft survival is closely associated with overall patient survival. Here, we present preclinical findings and discuss their possible impact on clinical liver transplantation. Then we discuss clinical studies designed to investigate how MSCs may be distributed and act in solid organ transplantation.",
"genre": "article",
"id": "sg:pub.10.1007/s12072-013-9509-1",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1038556",
"issn": [
"1936-0533",
"1936-0541"
],
"name": "Hepatology International",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "2",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "8"
}
],
"keywords": [
"clinical liver transplantation",
"solid organ transplantation",
"mesenchymal stem cells",
"liver transplantation",
"organ transplantation",
"efficacy of MSCs",
"cell therapy",
"immunomodulatory cell therapy",
"long-term immunosuppression",
"overall patient survival",
"severe side effects",
"organ allograft acceptance",
"application of MSCs",
"drug-related impairment",
"acute graft",
"host disease",
"allograft acceptance",
"renal function",
"kidney transplantation",
"graft survival",
"immunosuppressive drugs",
"opportunistic infections",
"patient survival",
"preclinical findings",
"standard pharmacotherapy",
"preclinical models",
"clinical studies",
"reduced dose",
"immune modulatory",
"solid organs",
"side effects",
"transplantation",
"clinical use",
"therapy",
"initial report",
"immunosuppression",
"regenerative properties",
"stem cells",
"survival",
"encouraging results",
"pharmacotherapy",
"malignancy",
"graft",
"infection",
"disease",
"dose",
"impairment",
"recipients",
"modulatory",
"drugs",
"efficacy",
"treatment",
"risk",
"vitro",
"organs",
"study",
"report",
"safety",
"cells",
"findings",
"possible impact",
"complement",
"effect",
"use",
"function",
"novel approach",
"acceptance",
"impact",
"great interest",
"area",
"results",
"interest",
"model",
"approach",
"properties",
"applications",
"methodology"
],
"name": "MSC-based therapies in solid organ transplantation",
"pagination": "179-184",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1003810089"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s12072-013-9509-1"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"26202500"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s12072-013-9509-1",
"https://app.dimensions.ai/details/publication/pub.1003810089"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:29",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_616.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s12072-013-9509-1"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12072-013-9509-1'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12072-013-9509-1'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12072-013-9509-1'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12072-013-9509-1'
This table displays all metadata directly associated to this object as RDF triples.
186 TRIPLES
22 PREDICATES
106 URIs
95 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s12072-013-9509-1 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1103 |
3 | ″ | schema:author | Nc3c625c3066a49ec9dd7168f5738d5c8 |
4 | ″ | schema:citation | sg:pub.10.1038/223472a0 |
5 | ″ | ″ | sg:pub.10.1038/nm.1905 |
6 | ″ | ″ | sg:pub.10.1186/1479-5876-9-124 |
7 | ″ | schema:datePublished | 2014-01-04 |
8 | ″ | schema:datePublishedReg | 2014-01-04 |
9 | ″ | schema:description | Immunomodulatory cell therapy as a complement to standard pharmacotherapy represents a novel approach to solid organ allograft acceptance. This methodology may allow for a reduced dose of immunosuppressive drug to be administered and thus attenuate the severe side effects associated with long-term immunosuppression such as drug-related impairment of renal function, increased risk from opportunistic infections and malignancies. Mesenchymal stem cells (MSCs) have been shown to possess both immune modulatory and regenerative properties in vitro and in preclinical models. Encouraging results have been reported from studies examining the safety and efficacy of MSCs as a treatment for acute graft-versus-host disease. MSCs represent a promising candidate cell therapy to supplement immunosuppression in recipients of solid organs, and initial reports on the clinical use of MSCs in kidney transplantation have been recently published (Tan et al. in J Am Med Assoc 307:1169–1177, 2012; Reinders et al. in Stem Cells Transl Med 2:107–111, 2013; Perico et al. in Transpl Int 26:867–878, 2013; Perico et al. in Clin J Am Soc Nephrol 6:412–422, 2011). An area of even greater interest might be the application of MSCs in clinical liver transplantation as graft survival is closely associated with overall patient survival. Here, we present preclinical findings and discuss their possible impact on clinical liver transplantation. Then we discuss clinical studies designed to investigate how MSCs may be distributed and act in solid organ transplantation. |
10 | ″ | schema:genre | article |
11 | ″ | schema:inLanguage | en |
12 | ″ | schema:isAccessibleForFree | false |
13 | ″ | schema:isPartOf | N0e1ec389494b49a28c7231015758e7c1 |
14 | ″ | ″ | N6a779d9b797f47d4ada87d2baf1ae45d |
15 | ″ | ″ | sg:journal.1038556 |
16 | ″ | schema:keywords | acceptance |
17 | ″ | ″ | acute graft |
18 | ″ | ″ | allograft acceptance |
19 | ″ | ″ | application of MSCs |
20 | ″ | ″ | applications |
21 | ″ | ″ | approach |
22 | ″ | ″ | area |
23 | ″ | ″ | cell therapy |
24 | ″ | ″ | cells |
25 | ″ | ″ | clinical liver transplantation |
26 | ″ | ″ | clinical studies |
27 | ″ | ″ | clinical use |
28 | ″ | ″ | complement |
29 | ″ | ″ | disease |
30 | ″ | ″ | dose |
31 | ″ | ″ | drug-related impairment |
32 | ″ | ″ | drugs |
33 | ″ | ″ | effect |
34 | ″ | ″ | efficacy |
35 | ″ | ″ | efficacy of MSCs |
36 | ″ | ″ | encouraging results |
37 | ″ | ″ | findings |
38 | ″ | ″ | function |
39 | ″ | ″ | graft |
40 | ″ | ″ | graft survival |
41 | ″ | ″ | great interest |
42 | ″ | ″ | host disease |
43 | ″ | ″ | immune modulatory |
44 | ″ | ″ | immunomodulatory cell therapy |
45 | ″ | ″ | immunosuppression |
46 | ″ | ″ | immunosuppressive drugs |
47 | ″ | ″ | impact |
48 | ″ | ″ | impairment |
49 | ″ | ″ | infection |
50 | ″ | ″ | initial report |
51 | ″ | ″ | interest |
52 | ″ | ″ | kidney transplantation |
53 | ″ | ″ | liver transplantation |
54 | ″ | ″ | long-term immunosuppression |
55 | ″ | ″ | malignancy |
56 | ″ | ″ | mesenchymal stem cells |
57 | ″ | ″ | methodology |
58 | ″ | ″ | model |
59 | ″ | ″ | modulatory |
60 | ″ | ″ | novel approach |
61 | ″ | ″ | opportunistic infections |
62 | ″ | ″ | organ allograft acceptance |
63 | ″ | ″ | organ transplantation |
64 | ″ | ″ | organs |
65 | ″ | ″ | overall patient survival |
66 | ″ | ″ | patient survival |
67 | ″ | ″ | pharmacotherapy |
68 | ″ | ″ | possible impact |
69 | ″ | ″ | preclinical findings |
70 | ″ | ″ | preclinical models |
71 | ″ | ″ | properties |
72 | ″ | ″ | recipients |
73 | ″ | ″ | reduced dose |
74 | ″ | ″ | regenerative properties |
75 | ″ | ″ | renal function |
76 | ″ | ″ | report |
77 | ″ | ″ | results |
78 | ″ | ″ | risk |
79 | ″ | ″ | safety |
80 | ″ | ″ | severe side effects |
81 | ″ | ″ | side effects |
82 | ″ | ″ | solid organ transplantation |
83 | ″ | ″ | solid organs |
84 | ″ | ″ | standard pharmacotherapy |
85 | ″ | ″ | stem cells |
86 | ″ | ″ | study |
87 | ″ | ″ | survival |
88 | ″ | ″ | therapy |
89 | ″ | ″ | transplantation |
90 | ″ | ″ | treatment |
91 | ″ | ″ | use |
92 | ″ | ″ | vitro |
93 | ″ | schema:name | MSC-based therapies in solid organ transplantation |
94 | ″ | schema:pagination | 179-184 |
95 | ″ | schema:productId | N35706b41a48f489a84353fc97ed02409 |
96 | ″ | ″ | N7837ba07a6334e96895374557f7297f8 |
97 | ″ | ″ | Nf601bafdeca04a15b814c372bf68d8eb |
98 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1003810089 |
99 | ″ | ″ | https://doi.org/10.1007/s12072-013-9509-1 |
100 | ″ | schema:sdDatePublished | 2022-05-20T07:29 |
101 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
102 | ″ | schema:sdPublisher | N003db0245e0f4a42b7b6c32e38ac76f4 |
103 | ″ | schema:url | https://doi.org/10.1007/s12072-013-9509-1 |
104 | ″ | sgo:license | sg:explorer/license/ |
105 | ″ | sgo:sdDataset | articles |
106 | ″ | rdf:type | schema:ScholarlyArticle |
107 | N003db0245e0f4a42b7b6c32e38ac76f4 | schema:name | Springer Nature - SN SciGraph project |
108 | ″ | rdf:type | schema:Organization |
109 | N0e1ec389494b49a28c7231015758e7c1 | schema:issueNumber | 2 |
110 | ″ | rdf:type | schema:PublicationIssue |
111 | N2b840d6c155b4c1cadaeb4e8ed7d3146 | rdf:first | sg:person.01001741457.76 |
112 | ″ | rdf:rest | rdf:nil |
113 | N35706b41a48f489a84353fc97ed02409 | schema:name | dimensions_id |
114 | ″ | schema:value | pub.1003810089 |
115 | ″ | rdf:type | schema:PropertyValue |
116 | N6a779d9b797f47d4ada87d2baf1ae45d | schema:volumeNumber | 8 |
117 | ″ | rdf:type | schema:PublicationVolume |
118 | N7837ba07a6334e96895374557f7297f8 | schema:name | pubmed_id |
119 | ″ | schema:value | 26202500 |
120 | ″ | rdf:type | schema:PropertyValue |
121 | N82a22d6fbda44e0084a480b50a3a46d7 | rdf:first | sg:person.0733752407.06 |
122 | ″ | rdf:rest | Ne23e16c83fdb4ceebb59b246d62503e5 |
123 | Nb2c9a822c14c4ab48daa28d755f55cc6 | rdf:first | sg:person.011340433274.43 |
124 | ″ | rdf:rest | N2b840d6c155b4c1cadaeb4e8ed7d3146 |
125 | Nc3c625c3066a49ec9dd7168f5738d5c8 | rdf:first | sg:person.01215502761.03 |
126 | ″ | rdf:rest | N82a22d6fbda44e0084a480b50a3a46d7 |
127 | Ne079442dfd0d40889d6017f8aea7612f | rdf:first | sg:person.01013422664.32 |
128 | ″ | rdf:rest | Nb2c9a822c14c4ab48daa28d755f55cc6 |
129 | Ne23e16c83fdb4ceebb59b246d62503e5 | rdf:first | sg:person.01152147001.88 |
130 | ″ | rdf:rest | Ne079442dfd0d40889d6017f8aea7612f |
131 | Nf601bafdeca04a15b814c372bf68d8eb | schema:name | doi |
132 | ″ | schema:value | 10.1007/s12072-013-9509-1 |
133 | ″ | rdf:type | schema:PropertyValue |
134 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
135 | ″ | schema:name | Medical and Health Sciences |
136 | ″ | rdf:type | schema:DefinedTerm |
137 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
138 | ″ | schema:name | Clinical Sciences |
139 | ″ | rdf:type | schema:DefinedTerm |
140 | sg:journal.1038556 | schema:issn | 1936-0533 |
141 | ″ | ″ | 1936-0541 |
142 | ″ | schema:name | Hepatology International |
143 | ″ | schema:publisher | Springer Nature |
144 | ″ | rdf:type | schema:Periodical |
145 | sg:person.01001741457.76 | schema:affiliation | grid-institutes:grid.7727.5 |
146 | ″ | schema:familyName | Popp |
147 | ″ | schema:givenName | F. C. |
148 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001741457.76 |
149 | ″ | rdf:type | schema:Person |
150 | sg:person.01013422664.32 | schema:affiliation | grid-institutes:grid.7727.5 |
151 | ″ | schema:familyName | Soeder |
152 | ″ | schema:givenName | Y. |
153 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013422664.32 |
154 | ″ | rdf:type | schema:Person |
155 | sg:person.011340433274.43 | schema:affiliation | grid-institutes:grid.7727.5 |
156 | ″ | schema:familyName | Dahlke |
157 | ″ | schema:givenName | M. D. |
158 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011340433274.43 |
159 | ″ | rdf:type | schema:Person |
160 | sg:person.01152147001.88 | schema:affiliation | grid-institutes:grid.7727.5 |
161 | ″ | schema:familyName | Johnson |
162 | ″ | schema:givenName | C. L. |
163 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152147001.88 |
164 | ″ | rdf:type | schema:Person |
165 | sg:person.01215502761.03 | schema:affiliation | grid-institutes:grid.7727.5 |
166 | ″ | schema:familyName | Benseler |
167 | ″ | schema:givenName | V. |
168 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215502761.03 |
169 | ″ | rdf:type | schema:Person |
170 | sg:person.0733752407.06 | schema:affiliation | grid-institutes:grid.7727.5 |
171 | ″ | schema:familyName | Obermajer |
172 | ″ | schema:givenName | N. |
173 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0733752407.06 |
174 | ″ | rdf:type | schema:Person |
175 | sg:pub.10.1038/223472a0 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1033985475 |
176 | ″ | ″ | https://doi.org/10.1038/223472a0 |
177 | ″ | rdf:type | schema:CreativeWork |
178 | sg:pub.10.1038/nm.1905 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1027601999 |
179 | ″ | ″ | https://doi.org/10.1038/nm.1905 |
180 | ″ | rdf:type | schema:CreativeWork |
181 | sg:pub.10.1186/1479-5876-9-124 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1026411869 |
182 | ″ | ″ | https://doi.org/10.1186/1479-5876-9-124 |
183 | ″ | rdf:type | schema:CreativeWork |
184 | grid-institutes:grid.7727.5 | schema:alternateName | Department of Surgery, University of Regensburg, Regensburg, Germany |
185 | ″ | schema:name | Department of Surgery, University of Regensburg, Regensburg, Germany |
186 | ″ | rdf:type | schema:Organization |